DETERMINE-preserved - Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Preserved Ejection Fraction
Clinical trial NCT03877224 · COMPLETED
Trial details
- NCT number
- NCT03877224
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-04
- Primary completion
- 2020-07-09
- Enrollment
- 504
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.